NCT06673225 INSPIRE Respiratory Health Program in Botucatu, São Paulo, Brazil
| NCT ID | NCT06673225 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UPECLIN HC FM Botucatu Unesp |
| Condition | Community Health Services |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-04-16 |
| Primary Completion | 2029-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-04-16 with a primary completion date of 2029-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the implementation of the INSPIRE program and to plan actions for the preparation, coordination, monitoring, diagnosis, and treatment of respiratory diseases in the municipality of Botucatu. Methods: Individuals with respiratory symptoms from the municipality of Botucatu, aged 18 or older, will be invited to participate in the study, and socioeconomic data, as well as information on sex, gender, race, nutritional risk, frailty, tobacco exposure, and its derivatives, will be collected. For those with exposure, screening and treatment for respiratory diseases will be offered through assessment of pulmonary function, body composition, respiratory and peripheral muscle strength. Additionally, individuals over 40 years old with tobacco exposure equal to or greater than 30 pack-years will be offered low-dose chest CT screening for lung cancer. Expected results: To identify and assess vulnerable groups that face difficulties in accessing respiratory healthcare, as well as implement specific strategies for the treatment of respiratory diseases and tobacco control for these groups. To ensure equitable access to respiratory health for the entire population at risk due to smoking. Moreover, through proactive and reactive risk reduction actions implemented by the program, to intervene in distinct groups and other regions.
Eligibility Criteria
Inclusion Criteria: * Age equal to or greater than 18 years old; * Respiratory symptoms * History of active or passive smoking * Signing of informed consent form Exclusion Criteria: * Difficulty understanding the issues addressed * Inability to contact by phone * Non-signing or withdrawal of informed consent
Contact & Investigator
Suzana E Tanni, MD-PhD
PRINCIPAL INVESTIGATOR
São Paulo State University (UNESP), Medical School, Botucatu
Frequently Asked Questions
Who can join the NCT06673225 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Community Health Services. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06673225 currently recruiting?
Yes, NCT06673225 is actively recruiting participants. Contact the research team at suzanapneumo@gmail.com for enrollment information.
Where is the NCT06673225 trial being conducted?
This trial is being conducted at Botucatu, Brazil.
Who is sponsoring the NCT06673225 clinical trial?
NCT06673225 is sponsored by UPECLIN HC FM Botucatu Unesp. The principal investigator is Suzana E Tanni, MD-PhD at São Paulo State University (UNESP), Medical School, Botucatu. The trial plans to enroll 2,000 participants.